Experts Advise Caution Following Study Indicating Testosterone Therapy May Treat Depression In Men

While new research suggests that testosterone therapy could be used to treat depression in men, some experts are urging the use of caution in interpreting those results. 

In a study published in JAMA Psychiatry on November 14, German researchers report that testosterone replacement therapy was linked to a significant reduction in symptoms of depression among men, particularly among those who received higher doses.

However, in an editorial published with the findings, researchers from Harvard and Columbia University questioned the quality of the evidence and warned that the side effects of testosterone treatments may outweigh any benefits for treating depression.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

The study involved a review and meta-analysis of 27 randomized, placebo-controlled clinical trials (RCTs), involving nearly 2,000 men. The researchers looked at alleviation of depressive symptoms, depression status, age, treatment duration and dosage.

According to the findings, men who took testosterone therapy were more than twice as likely to report a decrease in the symptoms of depression than men given a placebo. But the researchers warned that the studies they reviewed were never really meant to specifically examine testosterone’s effects on depression.

“Testosterone treatment appears to be effective and efficacious in reducing depressive symptoms in men, particularly when higher-dosage regimens were applied in carefully selected samples,” the researchers concluded. “However, given the heterogeneity of the included RCTs, more preregistered trials are needed that explicitly examine depression as the primary end point and consider relevant moderators.”

In an editorial published alongside the study’s findings, Shalendar Bhasin of Harvard Medical School and Brigham and Women’s Hospital in Boston, and Dr. Stuart Seidman from Columbia University in New York, warned that the findings do not include enough high quality evidence to say that testosterone therapy can be used to treat depression with any confidence.

“Although this meta-analysis adds to the body of data that testosterone administration may be associated with small improvements in depressive symptoms, we do not know whether these improvements are clinically meaningful,” they wrote. “Furthermore, neither the long-term safety nor the efficacy of testosterone therapy has been established in any depressive disorder. Because some of the adverse effects of testosterone are associated with its dose and on-treatment concentrations, the use of supraphysiologic doses of testosterone could be associated with increased risk of adverse effects and is currently not recommended.”

Testosterone Side Effects

The findings come following years of concerns that drugs have been over-marketed to men without any real medical need for the treatments, after findings that side effects of the low testosterone drugs may increase the risk of heart attacks, strokes and sudden death for men.

While medications like Androgel, Testim and others were originally intended as a “niche” treatment for men suffering from confirmed testosterone deficiency, amid aggressive marketing over the last decades, the drugs grew to generate billions in annual sales.

There are currently more than 6,000 Androgel lawsuits and other claims pending against makers of testosterone replacement therapy, alleging that users and the medical community were not adequately warned about the potential health risks, including an increased risk of heart attack, stroke, pulmonary embolism, deep vein thrombosis, blood clots and other life-threatening health problems.

Many of those cases are expected to be resolved through testosterone settlements reached in agreements over the summer.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Generic Depo-Provera Manufacturers Call for Birth Control Shot MDL to Be Created in NY, Not California
Generic Depo-Provera Manufacturers Call for Birth Control Shot MDL to Be Created in NY, Not California (Posted 2 days ago)

A growing number of lawsuits against generic Depo-Provera manufacturers have been filed throughout the federal court system, each alleging that women were not adequately warned about the risk of meningioma brain tumors from the birth control shot.

Oxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024
Oxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024 (Posted 3 days ago)

Former users of the recalled sickle cell disease drug Oxbryta have filed a class action lawsuit, claiming the manufacturer failed to warn consumers about risks associated with the medication, which can result in stroke and death.

Group of 20 Uber Driver Sexual Assault Lawsuits Will Be Prepared for Bellwether Trials in Dec. 2025
Group of 20 Uber Driver Sexual Assault Lawsuits Will Be Prepared for Bellwether Trials in Dec. 2025 (Posted 3 days ago)

Plaintiffs and defendants have each been directed to select 10 Uber driver sexual assault lawsuits to serve as potential bellwether trials by February 14, 2025, which will then go through case-specific discovery to prepare for early test trials.